Summary: A new study led by Stanford Medicine, published in JAMA Network Open, found that children who experience significant sleep disturbances, such as difficulty falling asleep or frequent nightmares, are at a heightened risk of developing suicidal thoughts and behaviors as … [Read more...]
Harmony Secures Rights to Develop Bioprojet’s Orexin-2 Agonist
Summary: Harmony Biosciences has secured an unique license from Bioprojet to establish, manufacture, and commercialize TPM-1116, an oral orexin-2 receptor agonist, in the United States and Latin The united states. This drug, aimed at dealing with narcolepsy and other rest … [Read more...]